We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.83%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
+$2.18B
(+5%)
Cap. Flow
+$425M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
15.17%
Holding
2,954
New
28
Increased
2,252
Reduced
604
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Baker Hughes
BKR
|
+$26.7M |
| 3 |
IQVIA
IQV
|
+$14.5M |
| 4 |
Oneok
OKE
|
+$14.3M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$114M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$88.6M |
| 3 |
BHI
Baker Hughes
BHI
|
+$41.6M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$26.7M |
| 5 |
UnitedHealth
UNH
|
+$22.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.64% |
| 2 | Technology | 15.8% |
| 3 | Healthcare | 13.57% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVID
2776
DELISTED
Avid Technology Inc
AVID
| $179K | ﹤0.01% |
39,502
+610
| +2% | +$2.89K |
|
|
SIFI
2777
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $179K | ﹤0.01% |
11,992
-350
| -3% | -$5.27K |
|
2778
Protagonist Therapeutics
PTGX
$8.79B
| $178K | ﹤0.01% |
10,096
+20
| +0.2% | +$277 |
|
2779
Ameresco
AMRC
$1.12B
| $177K | ﹤0.01% |
22,654
+40
| +0.2% | +$283 |
|
2780
Ampco-Pittsburgh
AP
$163M
| $177K | ﹤0.01% |
10,166
-120
| -1% | -$1.81K |
|
|
VRAY
2781
DELISTED
ViewRay, Inc.
VRAY
| $177K | ﹤0.01% |
30,647
+830
| +3% | +$4.68K |
|
|
AAC
2782
DELISTED
AAC Holdings
AAC
| $177K | ﹤0.01% |
17,777
-3,942
| -18% | -$33.7K |
|
2783
Fortress Biotech
FBIO
$104M
| $176K | ﹤0.01% |
2,649
+59
| +2% | +$3.98K |
|
|
BOCH
2784
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $176K | ﹤0.01% |
15,342
-750
| -5% | -$7.94K |
|
|
HDNG
2785
DELISTED
Hardinge Inc
HDNG
| $176K | ﹤0.01% |
11,524
-280
| -2% | -$3.76K |
|
2786
Tilly's
TLYS
$116M
| $175K | ﹤0.01% |
14,628
+270
| +2% | +$2.81K |
|
|
IVAC
2787
DELISTED
Intevac Inc
IVAC
| $175K | ﹤0.01% |
20,675
+430
| +2% | +$4.18K |
|
|
AGFS
2788
DELISTED
AgroFresh Solutions Inc
AGFS
| $175K | ﹤0.01% |
24,902
+1,569
| +7% | +$11.8K |
|
|
HIL
2789
DELISTED
Hill International, Inc. Common Stock
HIL
| $174K | ﹤0.01% |
36,628
+850
| +2% | +$4.13K |
|
2790
Donegal Group Class A
DGICA
$731M
| $173K | ﹤0.01% |
10,734
-318
| -3% | -$4.89K |
|
|
BFYT
2791
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $173K | ﹤0.01% |
11,920
+125
| +1% | +$3.45K |
|
2792
Clearfield
CLFD
$411M
| $172K | ﹤0.01% |
12,680
+325
| +3% | +$4.05K |
|
2793
Ooma
OOMA
$598M
| $171K | ﹤0.01% |
16,233
+210
| +1% | +$1.85K |
|
2794
Riverview Bancorp
RVSB
$107M
| $171K | ﹤0.01% |
20,338
+250
| +1% | +$1.93K |
|
2795
Anavex Life Sciences
AVXL
$255M
| $169K | ﹤0.01% |
40,937
+595
| +1% | +$2.65K |
|
|
XRN
2796
Chiron Real Estate Inc
XRN
$514M
| $169K | ﹤0.01% |
3,769
+229
| +6% | +$10.3K |
|
2797
Yext
YEXT
$547M
| $169K | ﹤0.01% |
12,741
+405
| +3% | +$5.37K |
|
|
TRVN
2798
DELISTED
Trevena, Inc.
TRVN
| $167K | ﹤0.01% |
105
+2
| +2% | +$3.15K |
|
|
HBP
2799
DELISTED
Huttig Building Products, Inc.
HBP
| $167K | ﹤0.01% |
23,691
+145
| +0.6% | +$916 |
|
2800
Fate Therapeutics
FATE
$286M
| $164K | ﹤0.01% |
41,527
+560
| +1% | +$1.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2017 Portfolio in Review
As of Q3 2017, RhumbLine Advisers held 2,954 positions worth $46B, up 5% from $43.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 2.6%. RhumbLine Advisers opened 28 new positions and exited 50, leaving the 2,954-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q3 2017 buy was Baker Hughes: 750,985 shares worth $27.5M.
- RhumbLine Advisers added most to DuPont de Nemours in Q3 2017, an estimated $128M increase.
- RhumbLine Advisers's biggest Q3 2017 reduction was UnitedHealth, cutting an estimated $22.8M.
- RhumbLine Advisers fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $114M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $46B portfolio in Q3 2017.
- RhumbLine Advisers opened 28 new positions and closed 50 in Q3 2017.
- RhumbLine Advisers's portfolio value rose 5% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q3 2017, filed 6 Nov 2017.